4rd Conference of Translational Medicine on the Pathogenesis and Therapy of Immune-Mediated Diseases
March 27-29, 2017
We are now approaching the 4th edition of the Conference of Translational Medicine on the Pathogenesis and Therapy of Immune-Mediated Diseases,. As you will see from the attached preliminary program and from our website ( www.translationalimmunology.it), the meeting will focus on innate immunity and inflammation in three models of human diseases: Autoinflammatory/Autoimmune Disorders, Cancer and Viral Infection.
The meeting will host 5 lectures from 5 pioneers in immunology: Charles Dinarello, Dan Kastner, Luigi Naldini, Alberto Mantovani and a last one to be still confirmed on HIV-1 infection. Short talks will be then selected from the submitted abstracts . As you can see from the attached preliminary program, a great interest is placed in the meeting to immunological disorders (PID, auto-inflammatory an autoimmune disorders, etc) and top scientists in this fields are comprised in the faculty of the meeting.
Being a meeting of Translational Immunology, our target are scientists working on human disease and physicians handling project of experimental medicine, as experienced on all three past editions. The format is also similar to Keystone or Gordon conferences with a given limit of 650 participants to make it possible interactive discussions, creation of networks and collaborations by setting up an intense social program with poster discussions, social dinners involving all delegates and faculty.
The second call has been launched just a few days ago and registration and abstract submission are now open (attached you will find also our newsletter). SIICA, Society of Leukocyte Biology, Italian Association of Cancer Research, EFIS, Humanitas University will support travel awards (proximately 25 up to now) for PhD students and junior PostDoc.
The meeting will also open its door to the African scientific community by involving the Pasteur Institute in Tunis and the Federation of African Immunologic Societies (FAIS) that also placed other 8 travel awards. Hence, Palermo will also serve a gateway to African biomedical-research community in order to build stronger e tight scientific networks with European and American networks.
The meeting is absolutely non-profit and all the funding we are currently raising from biotech/pharmaceutical companies or research institutions will cover the cost of the meeting and/or will be used to create travel awards an fellowships.